Caitong International Asset Management Co., LTD Cure Vac N.V. Transaction History
Caitong International Asset Management Co., LTD
- $134 Billion
- Q1 2025
A detailed history of Caitong International Asset Management Co., LTD transactions in Cure Vac N.V. stock. As of the latest transaction made, Caitong International Asset Management Co., LTD holds 1,233 shares of CVAC stock, worth $4,229. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,233Holding current value
$4,229% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CVAC
# of Institutions
93Shares Held
10.7MCall Options Held
75.1KPut Options Held
86.7K-
Black Rock Inc. New York, NY2.25MShares$7.73 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.82MShares$6.23 Million0.0% of portfolio
-
Bill & Melinda Gates Foundation Seattle, WA1.57MShares$5.38 Million10.6% of portfolio
-
Ubs Group Ag843KShares$2.89 Million0.0% of portfolio
-
Gsa Capital Partners LLP London, X0308KShares$1.06 Million0.08% of portfolio
About CureVac N.V.
- Ticker CVAC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 187,467,008
- Market Cap $643M
- Description
- CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...